The Latest Breaking News from Pfizer

Around 26m people across England eligible for autumn booster

The Biden administration is planning to stop paying for Covid vaccines and treatments, a move that could buoy some Covid stocks.

The government plans to buy 2.9 million doses of Covid-19 vaccine from Pfizer for children aged from six months to four years.

Moderna’s new dual-strain vaccine will be offered to millions of Britons ahead of winter

Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.

Britain became the first country to approve a “bivalent” jab on Monday that directly targets Omicron and the original Covid-19 strain - as 29 million people will initially be invited for the vaccine

Roughly 29 million people are eligible for an autumn booster but there are just 13 million doses of the new bivalent Moderna jab available

The S&P 500 is coming off its four-week win streak amid signals of cooling price increases. However, inflation is still running hot near a 40-year high, which might induce the Fed to continue its policy rate hikes. We think income stocks AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), Bristol-Myers Squibb (BMY),…

JCVI says mRNA vaccines such as the Pfizer and Moderna jabs are the most effective for UK booster programme

It's not known how long the vaccines will offer protection for, experts have admitted

In the U.S., officials have asked vaccine makers to target BA.5, rather than the original omicron strain. That has delayed the boosters' development — but officials hope they will be more effective.